Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
450 EGFR-TKI rechallenge restores sensitivity to targeted therapy by disrupting the dominance of resistant clones through chemotherapy-mediated clonal selection and population remodeling
In pre-clinical research, it is primarily studied for its effects on gastrointestinal healing, tendon and ligament repair, vascular growth (angiogenesis), and potential neuroprotective properties
We charge the following delivery fee: 4
US$ 24.25
US$ 28.91
US$ 27.97
US$ 23.46
US$ 20.37
